SERPINE1 and tuberculosis: Further research is needed to develop therapeutic interventions that specifically target elevated PAI-1 levels and enhance fibrinolytic activity in TB patients, ultimately mitigating the risks associated with the hypercoagulable state and improving clinical outcomes [53].